Geographic Infomation

9 Months Ended

Sep. 30, 2012

GEOGRAPHIC INFORMATION:

The Company and its subsidiaries are engaged in one line of business, the development, licensing, manufacturing and sale of pharmaceutical products. The Company conducts its international business through its Bermuda subsidiary which contracts with various manufacturers located in the United Kingdom, Switzerland and Italy, to make product for both its international and domestic operations. The Company’s international customers, Merck Serono and The Urology Company, sell its products into several countries.

As of July 2, 2010, with the completion of the Watson Transactions, Watson is responsible for the commercialization and sale of Progesterone Products domestically. The Company supplies Watson with finished products on a cost-plus-10% basis.

The following table shows selected information by geographic area:



	Net Revenues		Identifiable Assets
As of and for the nine months ended September 30, 2012
United States	$	6,443,375	$	28,087,985
Switzerland	12,293,740		4,934,873
Other countries	—		3,677,291
Total	$	18,737,115	$	36,700,149
As of and for the nine months ended September 30, 2011
United States	$	26,094,314	$	28,748,775
Switzerland	10,590,838		3,428,553
Other countries	—		2,457,273
Total	$	36,685,152	$	34,634,601